GLP-1 meaning: the hormone, the drug class and the medication list
GLP-1 is the abbreviation of glucagon-like peptide-1. Your intestine releases this hormone when you eat. It helps lower blood sugar and acts on the brain areas that control appetite.1 In everyday talk, “a GLP-1” means a prescription medication that imitates it, such as Ozempic®, Wegovy® or Zepbound®.
Key points
- The letters: glucagon-like peptide-1, a gut hormone.
- The drugs: GLP-1 receptor agonists copy it and last hours or days, not minutes.
- Not one drug: the class spans several ingredients. Tirzepatide adds a second target, GIP.
What does GLP-1 stand for?
Spelled out, GLP-1 is glucagon-like peptide-1. This hormone is a chain of 30 amino acids that L-cells in the wall of your gut release when you eat.5 Say it as “G-L-P one.” Each part means something:
- Glucagon-like: it is cut from proglucagon, the parent protein that also yields glucagon. Its function differs, because GLP-1 holds glucagon release down.5
- Peptide: a small string of amino acids.
- 1: researchers found two glucagon-like sequences in proglucagon and numbered them. GLP-2 is a separate hormone.6
“GLP-1” usually means the medication
Someone who says “I started a GLP-1” is taking a prescription drug such as Wegovy, Zepbound, Ozempic or Mounjaro®. In a KFF poll from late 2025, 18% of U.S. adults reported ever taking one, and 12% said they currently take one.4
What does GLP-1 receptor agonist mean?
It means a drug that attaches to the GLP-1 receptor and activates it, as your own GLP-1 does. The receptor is the docking point on a cell, and the agonist turns it on. The FDA shortens the class name to GLP-1 RAs.1
What does the GLP-1 hormone do?
GLP-1 is an incretin, a gut hormone that boosts insulin release after eating.5 It acts in three places:
| Where GLP-1 acts | What it does there | The result |
|---|---|---|
| Pancreas | Stimulates insulin and holds back glucagon | Smaller blood sugar rises after meals |
| Stomach | Slows digestion. The medications delay stomach emptying | Food leaves the stomach more slowly |
| Brain | Acts on areas that regulate appetite | Lower appetite and food intake |
Sources: FDA, Holst, Wegovy label.1,3,5
The insulin effect tracks blood sugar: the semaglutide and tirzepatide labels call it glucose-dependent.3,7
Why your own GLP-1 lasts only minutes
Natural GLP-1 has a half-life of 1.5 to 2 minutes, because an enzyme called DPP-4 inactivates it almost at once.2,5 Liraglutide has a half-life of about 13 hours and is taken daily.2 Semaglutide’s is about 1 week and tirzepatide’s about 5 days, so both are taken weekly.3,7
GLP-1 drugs list: which medications are GLP-1s?
The nine main GLP-1 brands in the United States, as of November 2026:
| Brand | Active ingredient | Maker | FDA-approved for | How it is taken |
|---|---|---|---|---|
| Ozempic | Semaglutide | Novo Nordisk | Type 2 diabetes, with heart and kidney risk uses | Weekly injection or daily tablet |
| Wegovy | Semaglutide | Novo Nordisk | Weight reduction, heart risk reduction and the liver disease MASH | Weekly injection or daily tablet |
| Rybelsus® | Semaglutide | Novo Nordisk | Type 2 diabetes | Daily tablet |
| Mounjaro | Tirzepatide (GIP and GLP-1) | Eli Lilly | Type 2 diabetes, with a heart risk use | Weekly injection |
| Zepbound | Tirzepatide (GIP and GLP-1) | Eli Lilly | Weight reduction, and sleep apnea in adults who have obesity | Weekly injection |
| Foundayo® | Orforglipron | Eli Lilly | Weight reduction | Daily tablet |
| Saxenda® | Liraglutide | Novo Nordisk | Weight reduction | Daily injection |
| Victoza® | Liraglutide | Novo Nordisk | Type 2 diabetes, with a heart risk use | Daily injection |
| Trulicity® | Dulaglutide | Eli Lilly | Type 2 diabetes, with a heart risk use | Weekly injection |
Summarized from each product’s prescribing information. Every use applies to specific patient groups.2,3,7,8,9,10,11,12,13 FDA data list Saxenda and the U.S. Rybelsus bottles as to be discontinued.14 Generic exenatide, the oldest GLP-1, is also sold.1
One ingredient, more than one brand
Ozempic and Wegovy are both semaglutide, Mounjaro and Zepbound are both tirzepatide, and Victoza and Saxenda are both liraglutide. Ozempic and Mounjaro have type 2 diabetes approvals and no weight loss approval, so prescribing either for weight is off-label.8,10 See Mounjaro vs Ozempic.
A short history of GLP-1 medications
- 2005The FDA approves the first GLP-1, exenatide (Byetta®).1 It copies a peptide first found in Gila monster saliva.6
- 2010 to 2014Victoza and Trulicity follow for type 2 diabetes. Saxenda is the first of the class with a weight management approval.1,12
- 2017 to 2021Semaglutide arrives as Ozempic, then Rybelsus, then Wegovy.1
- 2022 and 2023Tirzepatide is approved as Mounjaro, then as Zepbound.1
- 2025 and 2026Wegovy gains a tablet and a 7.2 mg weekly dose.3 Foundayo is approved, a daily tablet taken with or without food.1,11
What does GLP-1 mean for weight loss?
In weight loss, a GLP-1 is a prescription medication that lowers appetite and calorie intake through the GLP-1 receptor.3 Wegovy, Zepbound, Foundayo and Saxenda are the brands approved for it, each alongside a lower-calorie diet and more activity.3,7,11,12 For “food noise”, a term that often comes up alongside these medications, see the food noise score quiz.
The labels cover adults with obesity, or with overweight plus a weight-related condition. The NIH describes that as a BMI of 30 or greater, or 27 or greater with a problem such as high blood pressure or type 2 diabetes.15 Check yours with the BMI calculator.
GLP-1 vs GIP: what a dual agonist is
A dual agonist is one molecule that activates two receptors. Tirzepatide is one: it activates the GLP-1 and GIP receptors.7 GIP, short for glucose-dependent insulinotropic polypeptide, is a second gut hormone that boosts insulin after food.6
The FDA lists tirzepatide with the GLP-1 drugs and footnotes the second target,1 which is why Zepbound gets called “a GLP-1.” Our GLP-1 pipeline tracker follows drugs still in trials.
What are GLP-1s approved to treat?
Across the class, the FDA lists six approved uses. No product has them all:1
- Type 2 diabetes.
- Weight reduction and long-term maintenance.
- Lower risk of heart attack, stroke or death in certain adults with heart disease.
- Lower risk of worsening kidney disease in adults with type 2 diabetes.
- Moderate to severe obstructive sleep apnea in adults with obesity. See Zepbound for sleep apnea.
- MASH, a liver disease, with scarring.
GLP-1 glossary: 11 terms
| Term | Plain meaning |
|---|---|
| GLP-1 RA | GLP-1 receptor agonist, the formal name of the drug class |
| Agonist | A drug that attaches to a receptor and activates it |
| Dual agonist | One drug that activates two receptors. Tirzepatide activates GLP-1 and GIP |
| Incretin | A gut hormone that boosts insulin after food, such as GLP-1 or GIP |
| DPP-4 | The enzyme that inactivates your own GLP-1 within minutes |
| Half-life | The time it takes half of a drug to leave the blood |
| Titration | Raising the dose in steps, usually every 4 weeks for weekly injections |
| Boxed warning | A warning set in a box at the top of a drug’s label |
| Off-label | Use of a drug for something its FDA label does not list |
| Compounded | Prepared by a pharmacy for one patient. Not FDA-approved or FDA-reviewed |
| Prior authorization | A health plan’s sign-off before it pays for a medication |
What GLP-1 is not: terms people confuse
GLP-1 vs insulin
GLP-1 is not insulin. Insulin is a separate hormone, and GLP-1 prompts the pancreas to release it.5 Some people with type 2 diabetes take both medications, which raises the risk of low blood sugar.3
GLP-1 vs Ozempic
Ozempic is a single brand of semaglutide. The class has nine main brands, each with its own approved uses and doses.
GLP-1 “supplements,” patches and drops
No supplement, patch or drop is on the FDA’s list of approved GLP-1 medications, which are all prescription drugs.1 The FDA does not approve dietary supplements for safety or effectiveness before sale.16 It has also warned about counterfeit Ozempic and products sold online “for research purposes.”17
Compounded GLP-1 vs brand-name GLP-1
Compounded semaglutide and compounded tirzepatide are prepared by a pharmacy for an individual prescription. They are not FDA-approved, and the FDA does not review them for safety, effectiveness or quality. The FDA says they should be used only when an approved drug cannot meet a patient’s medical needs.17
Can food raise GLP-1 naturally?
Eating is what triggers your own GLP-1: L-cells release it when nutrients reach them.6 That signal fades within minutes, while a weekly medication stays in the blood for days.
GLP-1 side effects in brief
Stomach and bowel symptoms lead the list: nausea, diarrhea, vomiting, constipation and stomach pain. Nausea affected 44% of adults on Wegovy 2.4 mg against 16% on placebo, and 25% to 29% on Zepbound against 8% on placebo, in separate trials.3,7 Most episodes came while the dose was rising and eased over time.7
Serious side effects include pancreatitis, gallbladder problems, kidney injury from dehydration and serious allergic reactions.3 Most GLP-1 labels have a boxed warning on thyroid C-cell tumors, and the FDA is adding a warning about NAION, a rare cause of sudden vision loss.1 Read the safety information below and our GLP-1 side effects guide.
How do you get a GLP-1 medication?
You need a prescription. With Zealthy, you answer health questions online and a U.S.-licensed physician or nurse practitioner reviews them and prescribes only when a GLP-1 is appropriate. No live appointment is required to start, and eligible adults in all 50 states can join.
- Brand-name GLP-1s. Providers prescribe Ozempic, Wegovy, Zepbound or Mounjaro, sent to your own pharmacy. Our insurance coordination team submits the prior authorization. When your plan covers the medication, a member’s copay can be as low as $25 a month. Approval is never guaranteed.
- Compounded options. Compounded semaglutide costs $199 a month, or from $106 a month with a 3-month supply. Compounded tirzepatide costs $329 a month, or from $216 a month with a 3-month supply. Shipping from a partner pharmacy is included. Compounded drugs are not approved by the FDA, which does not review them for safety, effectiveness or quality.
- Membership. $39 covers the first month and each month after is $135, with unlimited secure messaging, optional video or phone visits, a weight loss coach and the Zealthy app. Medication is not included.
GLP-1 meaning: questions people ask
What is the full form of GLP-1?
The full form is glucagon-like peptide-1, a hormone of 30 amino acids that L-cells in your gut release when you eat. The name comes from proglucagon, the parent protein it shares with glucagon. The abbreviation also covers the medications that imitate it.
When people say they are on a GLP-1, what do they mean?
They mean a prescription medication from the GLP-1 receptor agonist class, such as Wegovy, Zepbound, Ozempic or Mounjaro. Nobody takes the natural hormone, because the body breaks it down within minutes. The medications last hours or days, so most are taken daily or weekly.
What is a GLP-1 receptor agonist in simple terms?
It is a drug that attaches to the GLP-1 receptor on your cells and activates it, as your own GLP-1 would. Semaglutide, liraglutide, dulaglutide and orforglipron are GLP-1 receptor agonists. Tirzepatide also activates the GIP receptor, which makes it a dual agonist.
Which medications are on the GLP-1 drugs list?
As of November 2026, the main U.S. brands are Ozempic, Wegovy and Rybelsus (semaglutide), Mounjaro and Zepbound (tirzepatide), Foundayo (orforglipron), Victoza and Saxenda (liraglutide) and Trulicity (dulaglutide). Wegovy, Zepbound, Foundayo and Saxenda are approved for weight reduction. The rest are approved for type 2 diabetes.
Is Ozempic a GLP-1 or a different kind of drug?
Ozempic is a GLP-1 medication. Its ingredient, semaglutide, is a GLP-1 receptor agonist made by Novo Nordisk. The FDA approved Ozempic for adults with type 2 diabetes, so using it for weight loss is off-label. Wegovy has the same ingredient and a weight reduction approval.
Are Zepbound and Mounjaro GLP-1s?
Yes, with a footnote. Both contain tirzepatide, which acts on the GLP-1 receptor plus a second receptor, GIP. The FDA groups tirzepatide with the GLP-1 medications and notes the second target. Zepbound is approved for weight reduction and Mounjaro for type 2 diabetes.
Does a GLP-1 work like insulin?
No. Insulin is a separate hormone made in the pancreas. GLP-1 prompts the pancreas to release its own insulin, in step with blood sugar. Taking a GLP-1 medication with insulin raises the chance of low blood sugar, so a prescriber may adjust the insulin dose.
Is there a GLP-1 pill?
Yes. Wegovy tablets and Foundayo are approved for weight reduction, and semaglutide tablets for type 2 diabetes are sold as Ozempic tablets and Rybelsus. Semaglutide tablets are taken on an empty stomach, at least 30 minutes before food. Foundayo has no food restriction.
Do you need a prescription for a GLP-1?
Yes. Every FDA-approved GLP-1 medication is prescription-only, and compounded versions, which are not FDA-approved, also require a prescription. The FDA urges people to buy only from state-licensed pharmacies and avoid products labeled for research use. At Zealthy, a licensed provider checks your health history before prescribing anything.
Important safety information for GLP-1 medications
A class summary from the Wegovy, Ozempic, Zepbound and Mounjaro labels.3,7,8,10 Read the Medication Guide for your own product.
Boxed warning: risk of thyroid C-cell tumors
Semaglutide and tirzepatide caused thyroid C-cell tumors in rodent studies. It is not known whether they cause these tumors, including medullary thyroid carcinoma (MTC), in people. Do not use them if you or a family member has had MTC, or if you have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Report a neck lump, trouble swallowing, shortness of breath or lasting hoarseness. The liraglutide, dulaglutide and orforglipron labels carry the same warning.
Do not use a GLP-1 medication if
- You or a family member has had MTC, or you have MEN 2.
- You have had a serious allergic reaction to the medication or an ingredient in it.
Tell your provider if you
- Have had pancreas problems, severe stomach problems such as gastroparesis, or diabetic retinopathy.
- Are pregnant, breastfeeding, planning a pregnancy, or due to have anesthesia or deep sedation.
- Take insulin, a sulfonylurea or birth control pills. Tirzepatide can make the pill less effective for 4 weeks after starting and after each dose increase.
Serious side effects
Pancreatitis, gallbladder problems, kidney injury from dehydration, severe stomach problems, low blood sugar (mainly with insulin or a sulfonylurea), serious allergic reactions, vision changes in people with type 2 diabetes, and food or liquid entering the lungs during anesthesia or deep sedation. Stop the medication and get medical help right away for severe stomach pain that will not go away, or for swelling of the face, lips, tongue or throat or trouble breathing.
The FDA is requiring every GLP-1 label to add a warning about a possible increased risk of NAION, a rare cause of vision loss. Contact a health care professional right away about sudden vision loss in one eye.1
Most common side effects
Nausea, diarrhea, vomiting, constipation and stomach pain. Report side effects to the FDA at 1-800-FDA-1088.
Product safety information
Ozempic, Wegovy, Mounjaro, Zepbound, semaglutide and tirzepatide.
Sources
- FDA. FDA requires safety labeling changes for GLP-1 receptor agonists due to potential increased risk of rare but serious eye condition. November 9, 2026. https://www.fda.gov/drugs/drug-safety-communications/fda-requires-safety-labeling-changes-glucagon-peptide-1-receptor-agonists-glp-1-ras-due-potential
- Victoza (liraglutide) Prescribing Information. Novo Nordisk. DailyMed. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5a9ef4ea-c76a-4d34-a604-27c5b505f5a4
- Wegovy (semaglutide) Prescribing Information. Novo Nordisk. Revised June 2026. DailyMed. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b
- KFF. KFF Health Tracking Poll: prescription drug costs, views on Trump administration actions, and GLP-1 use. November 2025. https://www.kff.org/public-opinion/kff-health-tracking-poll-prescription-drug-costs-views-on-trump-administration-actions-and-glp-1-use/
- Holst JJ. The physiology of glucagon-like peptide 1. Physiol Rev. 2007;87(4):1409-1439. https://pubmed.ncbi.nlm.nih.gov/17928588/
- Müller TD, Finan B, Bloom SR, et al. Glucagon-like peptide 1 (GLP-1). Mol Metab. 2019;30:72-130. https://pmc.ncbi.nlm.nih.gov/articles/PMC6812410/
- Zepbound (tirzepatide) Prescribing Information. Eli Lilly. Revised August 2026. DailyMed. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b
- Ozempic (semaglutide) Prescribing Information. Novo Nordisk. DailyMed. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=adec4fd2-6858-4c99-91d4-531f5f2a2d79
- Rybelsus (semaglutide) tablets and Ozempic (semaglutide) Prescribing Information. Novo Nordisk. Revised January 2026. DailyMed. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=27f15fac-7d98-4114-a2ec-92494a91da98
- Mounjaro (tirzepatide) Prescribing Information. Eli Lilly. DailyMed. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d2d7da5d-ad07-4228-955f-cf7e355c8cc0
- Foundayo (orforglipron) Prescribing Information. Eli Lilly. DailyMed. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8ac446c5-feba-474f-a103-23facb9b5c62
- Saxenda (liraglutide) Prescribing Information. Novo Nordisk. Revised February 2026. DailyMed. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3946d389-0926-4f77-a708-0acb8153b143
- Trulicity (dulaglutide) Prescribing Information. Eli Lilly. DailyMed. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=463050bd-2b1c-40f5-b3c3-0a04bb433309
- FDA. openFDA drug shortages data. Queried November 18, 2026. https://open.fda.gov/apis/drug/drugshortages/
- National Institute of Diabetes and Digestive and Kidney Diseases. Prescription medications to treat overweight and obesity. Reviewed June 2024. https://www.niddk.nih.gov/health-information/weight-management/prescription-medications-treat-overweight-obesity
- FDA. FDA 101: Dietary supplements. https://www.fda.gov/consumers/consumer-updates/fda-101-dietary-supplements
- FDA. FDA’s concerns with unapproved GLP-1 drugs used for weight loss. https://www.fda.gov/drugs/drug-alerts-and-statements/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss
Ready to ask a provider about a GLP-1?
Answer a few health questions online. A licensed provider reviews them, and membership starts at $39 for the first month.

Past the vocabulary, a licensed provider decides with you
A licensed Zealthy provider reviews your health history and explains which GLP-1 medication fits, if any.
The medical information on this page is reviewed by the Zealthy care team against FDA prescribing information and published clinical trials. It is general education, not personal medical advice.
What Zealthy members say
One of the things I appreciate most about semaglutide is its convenience. The once-weekly dosing schedule has made it incredibly easy to integrate into my routine. It's a relief to know that I don't have to worry about multiple daily injections or complicated medication schedules.
I started semaglutide at the recommendation of my Zealthy provider and I'm so happy with that decision. I signed up for their weight loss program and they've been giving me everything I need to make better lifestyle choices to get results that last. And the program's super affordable. 10/10 I can't recommend this enough.
Getting support a weight loss program has always been hard for me. I had been wanting to start one with a medication component for a while and Zealthy was the first one that made it easy for me with weight loss shots sent to me. They made it SO affordable and the medical team is great.
Since I started, I have already lost 35 pounds and feel so much better. My doctor also helped me get a prescription for ozempic and he is always available to answer my questions in the message portal. This made me feel a lot more comfortable and excited to lose weight.
The weight loss program is fantastic. Everyone has been so helpful and has helped me feel much more excited about the process. I was nervous to see my weight loss treatment plan, since I have done programs in the past, but they always wanted me to make drastic changes. I mentioned all of this to my weight loss coach and she was very understanding and made a customized plan for me.
I've been a member for 6 months now and have received all my medication every 3 months. Everyone has been so helpful and my care team is always available to help me!
Individual results may vary. These are the experiences of Zealthy members and are not a guarantee of any outcome. Medication is prescribed only when a licensed provider finds it appropriate.
GLP-1 medications Zealthy providers can prescribe
Brand-name or compounded, a licensed provider decides what fits your health history. Our insurance team handles the prior authorization paperwork for brand-name medication.
Zepbound®
Tirzepatide, FDA-approved for weight management and for sleep apnea in adults with obesity.
Zepbound cost, savings card and side effects →Wegovy®
Semaglutide, FDA-approved for weight management, as a weekly injection or a daily pill.
Wegovy pill, cost and side effects →Mounjaro®
Tirzepatide, FDA-approved for type 2 diabetes. The same ingredient as Zepbound.
Mounjaro doses and savings card →Ozempic®
Semaglutide, FDA-approved for type 2 diabetes. Weight loss is an off-label use.
Ozempic side effects and cost →Compounded semaglutide
$199 a month, or from $106 a month on a 3-month supply, shipping included. Not FDA-approved.
Semaglutide cost and dosing →Compounded tirzepatide
$329 a month, or from $216 a month on a 3-month supply, shipping included. Not FDA-approved.
Tirzepatide dosage and cost →Compounded medications are prepared by a partner pharmacy for an individual prescription. They are not FDA-approved, which means the FDA has not reviewed them for safety, effectiveness or quality. Zealthy membership ($39 for the first month, then $135 a month) is billed separately from medication. A prescription is written only if a licensed provider finds it appropriate.